Kurt Schalper
Anatomic Pathology & Clinical Pathology · New Haven, CTNPI 1689173809
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.8%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Merck at 30.6% of the total. Reporting peaked in 2023 at $67,553 and has fallen 65.0% since, to $23,641 in 2025. Among anatomic pathology & clinical pathology clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 89 payments — averaging $1556.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$42K
- F. Hoffmann-la Roche AG$39K
- Sanofi$18K
- Boehringer Ingelheim$12K
- EMD Serono, Inc.$11K
- Beckman Coulter, Inc.$3K
- plus $13K from 9 others
Across 33 payments — averaging $138,865 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$2.2M
- Roche Sequencing Solutions, Inc.$689K
- AstraZeneca$683K
- Genentech, Inc.$547K
- Merck$249K
- Astrazeneca UK Limited$166K
What the payments were for
- Consulting fees$63,44446%
- Speaking & faculty fees$29,07521%
- Travel & lodging$43,23831%
- Food & beverage$2,7262%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 16 | $42,398 |
| F. Hoffmann-la Roche AG | 15 | $38,970 |
| Sanofi | 12 | $18,328 |
| Boehringer Ingelheim | 18 | $11,699 |
| EMD Serono, Inc. | 10 | $10,923 |
| Beckman Coulter, Inc. | 1 | $3,250 |
| AbbVie | 2 | $3,150 |
| Roche Diagnostics Corporation | 1 | $2,225 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $2,160 |
| AstraZeneca | 1 | $1,815 |
| Pfizer | 1 | $1,400 |
| Johnson & Johnson | 1 | $1,240 |
| Regeneron | 6 | $742 |
| Astrazeneca UK Limited | 2 | $136 |
| Lilly USA, LLC | 2 | $48 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$138,484 in reported general payments places this provider in the 95th percentile of 94 anatomic pathology & clinical pathology providers in Connecticut.
See all anatomic pathology & clinical pathology providers in Connecticut →
Other anatomic pathology & clinical pathology in New Haven
- Marie RobertNew Haven$128K
- Mina XuNew Haven$9K
- Chen LiuNew Haven$9K
- Gilbert MoeckelNew Haven$2K
- Yuanxin LiangNew Haven$2K
- Alexa SiddonNew Haven$2K
- Paul FiedlerNew Haven$902
- He WangNew Haven$237
- Minhua WangNew Haven$159
- Il Song HahnNew Haven$153
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.